[go: up one dir, main page]

GB0409129D0 - New formulation - Google Patents

New formulation

Info

Publication number
GB0409129D0
GB0409129D0 GB0409129A GB0409129A GB0409129D0 GB 0409129 D0 GB0409129 D0 GB 0409129D0 GB 0409129 A GB0409129 A GB 0409129A GB 0409129 A GB0409129 A GB 0409129A GB 0409129 D0 GB0409129 D0 GB 0409129D0
Authority
GB
United Kingdom
Prior art keywords
new formulation
formulation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0409129A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEPTAGEN Ltd
Original Assignee
HEPTAGEN Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEPTAGEN Ltd filed Critical HEPTAGEN Ltd
Priority to GB0409129A priority Critical patent/GB0409129D0/en
Publication of GB0409129D0 publication Critical patent/GB0409129D0/en
Priority to PCT/GB2005/001532 priority patent/WO2005102296A2/en
Ceased legal-status Critical Current

Links

GB0409129A 2004-04-23 2004-04-23 New formulation Ceased GB0409129D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0409129A GB0409129D0 (en) 2004-04-23 2004-04-23 New formulation
PCT/GB2005/001532 WO2005102296A2 (en) 2004-04-23 2005-04-22 Combinations for the treatment of immunoproliferative skin disorders such as psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0409129A GB0409129D0 (en) 2004-04-23 2004-04-23 New formulation

Publications (1)

Publication Number Publication Date
GB0409129D0 true GB0409129D0 (en) 2004-05-26

Family

ID=32344316

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0409129A Ceased GB0409129D0 (en) 2004-04-23 2004-04-23 New formulation

Country Status (1)

Country Link
GB (1) GB0409129D0 (en)

Similar Documents

Publication Publication Date Title
ZA200801773B (en) New formulation
GB0421908D0 (en) New uses
TWI370115B (en) New formulation
GB0423565D0 (en) Formulation
GB0412530D0 (en) Formulation
EP1726304A4 (en) Solifenacin-containing composition
GB0526419D0 (en) Formulation
GB0418540D0 (en) Use
GB0517673D0 (en) Formulation
GB0407301D0 (en) Use
EP1833808A4 (en) New benzothiazolesulfonamides
GB0417702D0 (en) New uses
GB0410015D0 (en) Use
GB0501030D0 (en) Formulation
EP1781302A4 (en) New use
GB0412878D0 (en) Use
GB0419189D0 (en) New uses
GB0406951D0 (en) Improved formulation
PL1688129T3 (en) New therapeutic formulation
GB0409129D0 (en) New formulation
GB0412412D0 (en) New formulation
GB0426142D0 (en) Formulation
GB0407958D0 (en) Formulation
GB0401114D0 (en) Formulation
IL179208A0 (en) Intereferon formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)